Manufacturers Life Insurance Company, The Phathom Pharmaceuticals, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 13,594 shares of PHAT stock, worth $76,534. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,594
Previous 13,941
2.49%
Holding current value
$76,534
Previous $143,000
71.33%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding PHAT
# of Institutions
142Shares Held
74.8MCall Options Held
42.3KPut Options Held
45.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.1MShares$56.9 Million9.84% of portfolio
-
Medicxi Ventures Management (Jersey) LTD7.46MShares$42 Million13.31% of portfolio
-
Jennison Associates LLC7.06MShares$39.8 Million0.04% of portfolio
-
Invesco Ltd. Atlanta, GA4.1MShares$23.1 Million0.01% of portfolio
-
Carlyle Group Inc. Washington, DC3.5MShares$19.7 Million9.52% of portfolio
About Phathom Pharmaceuticals, Inc.
- Ticker PHAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,175,200
- Market Cap $221M
- Description
- Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...